Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025. In the quarter to August 2026, revenue grew 6.51%, EPS fell 132.1%, free cash flow grew 135.8% and total debt fell 2.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

11.81 0.46 −3.75%
Market cap
$2.7B
P/E
0.0×
Fwd P/E
−36.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a
Older periods Nov '25 Feb '26 May '26 Aug '26
Piotroski F-Score

+8 more TTM periods

4 4 5 6
ROE
(25.25%) (25.56%) (0.38%) (2.67%)
ROA
(16.26%) (16.46%) (0.23%) (1.68%)
ROIC
(14.24%) (14.53%) (0.50%) (0.17%)
Return on Tangible Assets
(79.31%) (78.93%) (1.02%) (7.36%)
Average Days of Receivables
54.73 57.48 61.56 56.24
Free Cash Flow per Share
(0.08) 0.03 0.15 0.23
Free Cash Flow
(17.87) 6.30 32.00 49.85
Other line items

Show all line items

Columns are period end dates · fundamentals updated 13 Oct 2026